Newsroom

Sorted by: Latest

-

Balyasny Asset Management LP UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Balyasny Asset Management L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be...
-

Balyasny Asset Management LP UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Balyasny Asset Management L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be...
-

LSI Industries Reports Fiscal 2026 Fourth Quarter and Full-Year Results and Declares Quarterly Cash Dividend

CINCINNATI--(BUSINESS WIRE)--LSI Industries Inc. (Nasdaq: LYTS, “LSI” or the “Company”) a leading U.S. based manufacturer of commercial lighting and display solutions, today reported financial results for its fiscal 2026 fourth quarter and full year ended June 30, 2026. FISCAL 2026 FOURTH QUARTER RESULTS Net Sales +51% y/y to $234.6 million; organic growth +8% Net Income $6.9 million; Adjusted Net Income $14.4 million Diluted EPS of $0.18; Adjusted EPS $0.38 per diluted share EBITDA $21.2 milli...
-

Natuzzi S.p.A. Enters Into a Definitive Agreement With Selected Candidate for Chief Executive Officer Role

SANTERAMO IN COLLE, Bari, Italy--(BUSINESS WIRE)--NATUZZI S.P.A. ENTERS INTO A DEFINITIVE AGREEMENT WITH SELECTED CANDIDATE FOR CHIEF EXECUTIVE OFFICER ROLE...
-

Capella University Announces Appointment of Oncology Leader Dr. Saro Sarkisian to Board of Trustees

MINNEAPOLIS--(BUSINESS WIRE)--Capella University is pleased to announce the appointment of Saro Sarkisian, MD, MHA, to its Board of Trustees....
-

Walmart reports revenue growth of 5.9%, up 5.1% in constant currency (cc)

BENTONVILLE, Ark.--(BUSINESS WIRE)--Walmart Inc. (Nasdaq: WMT): Second Quarter Highlights: Revenue of $187.9 billion, up 5.9%, or 5.1% (cc) Global eCommerce sales grew 23%, led by store-fulfilled pickup & delivery and marketplace Global advertising business up 38%, with strength across segments. Walmart U.S. advertising up 38% Membership fee revenue grew 17% globally Gross profit rate up 96 bps, led by Walmart U.S., primarily impacted by tariff refund impacts noted below Operating income up...
-

Performance Food Group Company Announces Board Updates

RICHMOND, Va.--(BUSINESS WIRE)--Performance Food Group Company (“PFG” or the “Company”) (NYSE: PFGC) today announced that the independent directors of the Company’s Board of Directors (the “Board”) have elected Matthew C. Flanigan to serve as Lead Independent Director following PFG’s 2026 Annual Meeting of Stockholders (the “Annual Meeting”). Flanigan, who currently chairs the Board’s Audit and Finance Committee, will succeed Manuel A. Fernandez, who has served in the role since 2019. The Compa...
-

Serif Health Receives Significant Growth Investment From SEVA

SAN FRANCISCO--(BUSINESS WIRE)--Serif Health (“Serif” or the “Company”), the leading provider of healthcare price transparency data and intelligence, today announced a significant minority investment from SEVA Growth LP (“SEVA”). The proceeds from the transaction will be used to accelerate Serif’s sales and growth initiatives, and its pipeline of new product functionality and data APIs. Shalin Mehta, SEVA Founder and Managing Partner, will also join Serif’s Board of Directors as part of the agr...
-

Ionis to present new data strengthening leadership in the management of severe hypertriglyceridemia (sHTG) at the European Society of Cardiology Congress 2026

CARLSBAD, Calif.--(BUSINESS WIRE)--Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that new data in the management of severe hypertriglyceridemia (sHTG) will be presented at the European Society of Cardiology (ESC) Congress 2026, taking place August 28 – 31 in Munich. Presentations include one-year data from the open-label, long-term extension study of TRYNGOLZA® (olezarsen), recently approved in the U.S. as the first and only treatment for sHTG to reduce triglycerides and the risk o...
-

Pitney Bowes Inc. Commences Cash Tender Offers for Two Series of Notes

SHELTON, Conn.--(BUSINESS WIRE)--Pitney Bowes Inc. (NYSE:PBI) (“Pitney Bowes” or the “Company”) announced the commencement of tender offers to purchase (each offer a “Tender Offer” and collectively, the “Tender Offers”), subject to certain terms and conditions, up to $50,000,000 aggregate principal amount (subject to increase or decrease by the Company, the “Maximum Tender Amount”) of its outstanding 6.70% Notes due 2043 (the “2043 Notes”) and 5.250% Medium-Term Notes due 2037 (the “2037 Notes”...